Ganesh Gollavelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Ganesh Gollavelli has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Chiranjeevi Korupalli
Department of Biological Sciences, School of Engineering and Sciences, Sri Ramaswamy Memorial University (SRM) University-Andhra Pradesh (AP)
1 shared publicationChiranjib Patra
Department of Biological Sciences, School of Engineering and Sciences, Sri Ramaswamy Memorial University (SRM) University-Andhra Pradesh (AP)
1 shared publicationGanesh Kamble
Department of Engineering Chemistry, Kolhapur Institute of Technology, College of Engineering (Empowered Autonomous)
1 shared publicationKarthik Nuthalapati
Experimental Physics and Center for Biophysics, Saarland University
1 shared publicationSuresh Thangudu
Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Malaria
- Vol. 4, 1925644
Advanced nanomaterials for malaria theranostics
Malaria is still one of the world’s most devastating infectious diseases, even with significant progress in treatment, mosquito control, and vaccines. The rise of drug-resistant Plasmodium parasites and insecticide-resistant Anopheles mosquitoes, along with limitations in traditional diagnosis and treatment methods, continue to hinder efforts to eliminate malaria globally. Nanotechnology has emerged as a valuable approach to address these issues. It offers highly sensitive diagnosis, targeted drug delivery, controlled drug release, vaccine development, and better mosquito management. This review critically highlights the latest advancements in nanotheranostics of malaria based on metal, metal oxides, carbon-based, polymeric, lipid-based, and other hybrid nanomaterials for malaria vaccine delivery and vector control, along with theranostics. The review also highlights key challenges such as nanotoxicity, safety for the environment, manufacturing challenges, consistency, and regulatory issues, along with recent advancements in nanomedicine and artificial-intelligence-based malaria diagnosis systems. Overall, this review underscores the growing potential of innovative nanomaterials to advance malaria diagnosis, treatment, and prevention while pointing out essential research areas needed for successful clinical use.
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Malaria
- Vol. 4, 1925644
Open AccessAdvanced nanomaterials for malaria theranostics
Malaria is still one of the world’s most devastating infectious diseases, even with significant progress in treatment, mosquito control, and vaccines. The rise of drug-resistant Plasmodium parasites and insecticide-resistant Anopheles mosquitoes, along with limitations in traditional diagnosis and treatment methods, continue to hinder efforts to eliminate malaria globally. Nanotechnology has emerged as a valuable approach to address these issues. It offers highly sensitive diagnosis, targeted drug delivery, controlled drug release, vaccine development, and better mosquito management. This review critically highlights the latest advancements in nanotheranostics of malaria based on metal, metal oxides, carbon-based, polymeric, lipid-based, and other hybrid nanomaterials for malaria vaccine delivery and vector control, along with theranostics. The review also highlights key challenges such as nanotoxicity, safety for the environment, manufacturing challenges, consistency, and regulatory issues, along with recent advancements in nanomedicine and artificial-intelligence-based malaria diagnosis systems. Overall, this review underscores the growing potential of innovative nanomaterials to advance malaria diagnosis, treatment, and prevention while pointing out essential research areas needed for successful clinical use.